Connor, Clark & Lunn Investment Management (CC&L)’s BeOne Medicines Ltd. American Depositary Shares ONC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $73.3M | Buy |
302,999
+11,393
| +4% | +$2.76M | 0.26% | 76 |
|
|
2025
Q1 | $79.4M | Buy |
291,606
+7,212
| +3% | +$1.96M | 0.35% | 55 |
|
|
2024
Q4 | $52.5M | Buy |
284,394
+58,540
| +26% | +$10.8M | 0.24% | 71 |
|
|
2024
Q3 | $50.7M | Buy |
225,854
+138,978
| +160% | +$31.2M | 0.25% | 66 |
|
|
2024
Q2 | $12.4M | Buy |
86,876
+21,260
| +32% | +$3.03M | 0.05% | 249 |
|
|
2024
Q1 | $10.3M | Buy |
65,616
+32,252
| +97% | +$5.04M | 0.04% | 292 |
|
|
2023
Q4 | $6.02M | Buy |
33,364
+30,869
| +1,237% | +$5.57M | 0.03% | 375 |
|
|
2023
Q3 | $449K | Sell |
2,495
-14,331
| -85% | -$2.58M | ﹤0.01% | 1040 |
|
|
2023
Q2 | $3M | Sell |
16,826
-15,361
| -48% | -$2.74M | 0.02% | 501 |
|
|
2023
Q1 | $6.94M | Sell |
32,187
-18,758
| -37% | -$4.04M | 0.04% | 310 |
|
|
2022
Q4 | $11.2M | Buy |
50,945
+24,922
| +96% | +$5.48M | 0.06% | 211 |
|
|
2022
Q3 | $3.51M | Buy |
26,023
+18,417
| +242% | +$2.48M | 0.02% | 390 |
|
|
2022
Q2 | $1.23M | Buy |
7,606
+2,967
| +64% | +$480K | 0.01% | 571 |
|
|
2022
Q1 | $875K | Buy |
4,639
+3,404
| +276% | +$642K | ﹤0.01% | 690 |
|
|
2021
Q4 | $335K | Buy |
+1,235
| New | +$335K | ﹤0.01% | 869 |
|
|
2021
Q1 | – | Sell |
-7,833
| Closed | -$2.02M | – | 1113 |
|
|
2020
Q4 | $2.02M | Buy |
+7,833
| New | +$2.02M | 0.01% | 508 |
|